Shenfu Injection + 5% Glucose Injection
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Myocardial Infarction
Conditions
Myocardial Infarction
Trial Timeline
Apr 1, 2016 → Feb 1, 2018
NCT ID
NCT02709798About Shenfu Injection + 5% Glucose Injection
Shenfu Injection + 5% Glucose Injection is a approved stage product being developed by China Resources Pharmaceutical Group for Myocardial Infarction. The current trial status is completed. This product is registered under clinical trial identifier NCT02709798. Target conditions include Myocardial Infarction.
What happened to similar drugs?
9 of 20 similar drugs in Myocardial Infarction were approved
Approved (9) Terminated (1) Active (11)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02709798 | Approved | Completed |
Competing Products
20 competing products in Myocardial Infarction